Onconetix, Inc.
Develops diagnostics and therapeutics for men's health and oncology markets.
ONCO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US68237Q1040 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 201 E. FIFTH STREET, 45202 CINCINNATI
- Website:
- https://www.onconetix.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of proprietary solutions, primarily in the areas of men's health and oncology. The company develops and markets innovative therapeutics and diagnostics. Its key commercial product is Proclarix®, an in vitro diagnostic test used for the risk assessment of prostate cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Onconetix, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onconetix, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onconetix, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
